CNBC’s Angelica Peebles and Eli Lilly chairman and CEO David Ricks join ‘Squawk on the Street’ to discuss results of the company’s 3-year obesity study, which showed its highly popular weight loss drug reduced the risk of developing Type 2 diabetes by 94% in obese or overweight adults with prediabetes compared with a placebo.

Related Videos :







Eli Lilly CEO on why food companies haven't seen a big impact on sales [BnTpu1KRP]

Eli Lilly CEO on why food companies haven't seen a big impact on sales [BnTpu1KRP]

CNBC’s Angelica Peebles and Eli Lilly chairman and CEO David Ricks join ‘Squawk on the Street’ to discuss results of the company’s 3-year obesity study, which showed its highly popular weight loss drug reduced the risk of developing Type 2 diabetes by 94% in obese or overweight adults with prediabetes compared with a placebo.

Related Videos :

Aired: December 3rd 2024

Rating: TV-14

Buy Now:

Problems Playing Video? | Closed Captioning

Related to This Episode

  • Q&A with Heidi Thomas

    Q&A with Heidi Thomas

    Writer & Executive Producer of Eli Lilly CEO on why food companies haven't seen a big impact on sales [BnTpu1KRP] on the secret of the show.

  • Relive the Drama with Gif Recaps

    Relive the Drama with Gif Recaps

    Miss an episode? Catch up on all things Poplar with our gif recaps.

  • Visit the Official Site

    Visit the Official Site

    Dive deeper into Eli Lilly CEO on why food companies haven't seen a big impact on sales [BnTpu1KRP] with cast Q&As, expert blogs, BTS photos, and more!

  • Explore the Modern Midwives Blog

    Explore the Modern Midwives Blog

    Experienced midwives discuss how Eli Lilly CEO on why food companies haven't seen a big impact on sales [BnTpu1KRP] intersects with modern day Midwifery.

Learn About Midwifery Today

Blog

Learn About Midwifery Today

Read the Modern Day Midwives Blog and learn more about our bloggers, all experienced midwives.

Read now